Leiomyosarcoma of the inferior vena cava: experience in 22 cases.
From 1979 to 2004, 22 patients were seen with leiomyosarcomas of the inferior vena cava (IVC). Twenty were treated surgically. Involvement of the IVC included the infrarenal segment in 3 cases, the suprarenal and/or retrohepatic segment in 13, and the suprahepatic segment in 4. Nineteen patients underwent wide tumor resection followed by ligation of the IVC in 5 cases, replacement with a PTFE prosthesis in 13, and cavoplasty in 1. An intracardiac tumor extension was resected during hypothermic circulatory arrest in 1 patient. Vascular exclusion of the liver was used in 5 cases and simple clamping of the IVC in 13 cases. There were 1 intraoperative death due to cardiac failure and 3 postoperative deaths due to multiple organ failure, liver failure, and duodenal fistula after treatment of a bleeding ulcer. Fifteen of the 16 surviving patients underwent adjuvant chemotherapy associated with radiation therapy in 4 cases. One patient was lost from follow-up at 10 months. Four patients including one with metastasis are still alive with a mean follow-up of 18.3 months. Eleven patients died after a mean follow-up period of 43.7 months due to local recurrence and/or distant metastasis in 9 cases and complications of chemotherapy in 2. The 3- and 5-year mean actuarial survival rates in patients who underwent resection were 52.0% and 34.8%, respectively. Leiomyosarcoma of the IVC is a serious disease. Although surgical resection combined with chemotherapy is usually not curative, it can achieve reasonably long-term survival. We recommend aggressive operative management using the latest vascular surgery and oncology techniques.
Kieffer
Edouard
E
Department of Vascular Surgery, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. edouard.kieffer@psl.aphp.fr
Alaoui
Mustapha
M
Piette
Jean-Charles
JC
Cacoub
Patrice
P
Chiche
Laurent
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019917:Blood Vessel Prosthesis Implantation; D002423:Cause of Death; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006324:Heart Arrest, Induced; D006338:Heart Neoplasms / Q000601:surgery; D006801:Humans; D007036:Hypothermia, Induced; D007431:Intraoperative Complications; D007890:Leiomyosarcoma / Q000556:secondary / Q000601:surgery*; D008026:Ligation; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D011138:Polytetrafluoroethylene; D011183:Postoperative Complications; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate; D019043:Vascular Neoplasms / Q000601:surgery*; D014682:Vena Cava, Inferior / Q000601:surgery*
D011138:Polytetrafluoroethylene